The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Cell Cycle Control and Cancer
Abstract
Multiple genetic changes occur during the evolution of normal cells into cancer cells. This evolution is facilitated in cancer cells by loss of fidelity in the processes that replicate, repair, and segregate the genome. Recent advances in our understanding of the cell cycle reveal how fidelity is normally achieved by the coordinated activity of cyclin-dependent kinases, checkpoint controls, and repair pathways and how this fidelity can be abrogated by specific genetic changes. These insights suggest molecular mechanisms for cellular transformation and may help to identify potential targets for improved cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
Cited by
Items 101–179 of 179
Ellison, V., & Stillman, B. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000033 · Cited by 363
Shimizu, N., Itoh, N., Utiyama, H., & Wahl, G. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1307 · Cited by 361
Yamamoto, A., Guacci, V, & Koshland, D. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.1.99 · Cited by 350
Singh, S. V., Herman-Antosiewicz, A., Singh, A. V., Lew, K. L., Srivastava, S. K., Kamath, R., Brown, K. D., Zhang, L., & Baskaran, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313538200 · Cited by 347
Vairapandi, M., Balliet, A. G., Hoffman, B., & Liebermann, D. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10140 · Cited by 347
Pestov, D. G., Strezoska, Ž., & Lau, L. F. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4246-4255.2001 · Cited by 342
GADD45 Proteins: Central Players in Tumorigenesis
E. Tamura, R., F. de Vasconcellos, J., Sarkar, D., A. Libermann, T., B. Fisher, P., & F. Zerbini, L. (2012) · Current Molecular Medicine · doi:10.2174/156652412800619978 · Cited by 340
Babu, J. R., Jeganathan, K. B., Baker, D. J., Wu, X., Kang-Decker, N., & van Deursen, J. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211048 · Cited by 339
Activation of the Budding Yeast Spindle Assembly Checkpoint Without Mitotic Spindle Disruption
Hardwick, K. G., Weiss, E., Luca, F. C., Winey, M., & Murray, A. W. (1996) · Science · doi:10.1126/science.273.5277.953 · Cited by 337
A CAF-1–PCNA-Mediated Chromatin Assembly Pathway Triggered by Sensing DNA Damage
Moggs, J. G., Grandi, P., Quivy, J.-P., Jónsson, Z. O., Hübscher, U., Becker, P. B., & Almouzni, G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1206-1218.2000 · Cited by 336
Protein kinases as targets for anticancer agents: from inhibitors to useful drugs
Fabbro, D., Ruetz, S., Buchdunger, E., Cowan-Jacob, S. W., Fendrich, G., Liebetanz, J., Mestan, J., O'Reilly, T., Traxler, P., Chaudhuri, B., et al. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00179-1 · Cited by 335
Schultz, C., Link, A., Leost, M., Zaharevitz, D. W., Gussio, R., Sausville, E. A., Meijer, L., & Kunick, C. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900570 · Cited by 334
Zhang, W., Geiman, D. E., Shields, J. M., Dang, D. T., Mahatan, C. S., Kaestner, K. H., Biggs, J. R., Kraft, A. S., & Yang, V. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000062200 · Cited by 327
Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation
Sielecki, T. M., Boylan, J. F., Benfield, P. A., & Trainor, G. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990256j · Cited by 323
Macleod, K. F., Hu, Y., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01006.x · Cited by 321
Miyajima, A., Chen, J., Lawrence, C., Ledbetter, S., Soslow, R. A., Stern, J., Jha, S., Pigato, J., Lemer, M. L., Poppas, D. P., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00414.x · Cited by 321
Choudhuri, T., Pal, S., Das, T., & Sa, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410670200 · Cited by 321
Recombination Regulation by Transcription-Induced Cohesin Dissociation in rDNA Repeats
Kobayashi, T., & Ganley, A. R. D. (2005) · Science · doi:10.1126/science.1116102 · Cited by 316
(2000) · PubMed · Cited by 314
Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases
Giet, R., & Prigent, C. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.21.3591 · Cited by 314
Sun, Z., Fay, D. S., Marini, F., Foiani, M., & Stern, D. F. (1996) · Genes & Development · doi:10.1101/gad.10.4.395 · Cited by 300
Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer
Chan, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602162 · Cited by 301
Cordon-Cardo, C., Koff, A., Drobnjak, M., Capodieci, P., Osman, I., Millard, S. S., Gaudin, P. B., Fazzari, M., Zhang, Z.-F., Massague, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1284 · Cited by 300
Multistep carcinogenesis of breast cancer and tumour heterogeneity
Beckmann, M. W., Niederacher, D., Schnürch, H.-G., Gusterson, B. A., & Bender, H. G. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050128 · Cited by 299
Caffeine inhibits the checkpoint kinase ATM
Blasina, A., Price, B. D., Turenne, G. A., & McGowan, C. H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80486-2 · Cited by 295
Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F., & Karin, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00193-8 · Cited by 295
Differentiation therapy of human cancer: basic science and clinical applications
Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., & Fisher, P. B. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00132-2 · Cited by 292
Vialard, J. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5679 · Cited by 284
Narayanan, B. A., Geoffroy, O., Willingham, M. C., Re, G. G., & Nixon, D. W. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00323-1 · Cited by 283
Keegan, K. S., Holtzman, D. A., Plug, A. W., Christenson, E. R., Brainerd, E. E., Flaggs, G., Bentley, N. J., Taylor, E. M., Meyn, M. S., Moss, S. B., et al. (1996) · Genes & Development · doi:10.1101/gad.10.19.2423 · Cited by 282
Zhou, B.-B. S., Chaturvedi, P., Spring, K., Scott, S. P., Johanson, R. A., Mishra, R., Mattern, M. R., Winkler, J. D., & Khanna, K. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10342 · Cited by 278
p38 Kinase Mediates UV-induced Phosphorylation of p53 Protein at Serine 389
Huang, C., Ma, W.-Y., Maxiner, A., Sun, Y., & Dong, Z. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12229 · Cited by 275
Cell-cycle control and its watchman
Jacks, T., & Weinberg, R. A. (1996) · Nature · doi:10.1038/381643a0 · Cited by 274
Kalin, T. V., Wang, I.-C., Ackerson, T. J., Major, M. L., Detrisac, C. J., Kalinichenko, V. V., Lyubimov, A., & Costa, R. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3138 · Cited by 274
cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein.
Cimprich, K. A., Shin, T. B., Keith, C. T., & Schreiber, S. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2850 · Cited by 273
Senescent cells develop a parp-1 and nuclear factor-κB-associated secretome (PNAS).
Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P., et al. (2011) · Genes & Development · doi:10.1101/gad.625811 · Cited by 267
Fussenegger, M., Schlatter, S., Dätwyler, D., Mazur, X., & Bailey, J. E. (1998) · Nature Biotechnology · doi:10.1038/nbt0598-468 · Cited by 269
Sensing and responding to DNA damage
Lowndes, N. F., & Murguia, J. R. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00050-7 · Cited by 266
ICE/CED3-like Proteases as Therapeutic Targets for the Control of Inappropriate Apoptosis
Nicholson, D. W. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-297 · Cited by 265
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
Kaufmann, S. H., & Vaux, D. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206945 · Cited by 265
Xiao, D. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg023 · Cited by 265
Minn, A. J., Boise, L. H., & Thompson, C. B. (1996) · Genes & Development · doi:10.1101/gad.10.20.2621 · Cited by 263
Induction of DNA synthesis and apoptosis are separable functions of E2F-1.
Phillips, A. C., Bates, S., Ryan, K. M., Helin, K., & Vousden, K. H. (1997) · Genes & Development · doi:10.1101/gad.11.14.1853 · Cited by 259
Inoue, T., Hiratsuka, M., Osaki, M., Yamada, H., Kishimoto, I., Yamaguchi, S., Nakano, S., Katoh, M., Ito, H., & Oshimura, M. (2007) · Oncogene · doi:10.1038/sj.onc.1209857 · Cited by 258
Cell cycle control, checkpoint mechanisms, and genotoxic stress.
Shackelford, R. E., Kaufmann, W. K., & Paules, R. S. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s15 · Cited by 257
Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.
Rhind, N., Furnari, B., & Russell, P. (1997) · Genes & Development · doi:10.1101/gad.11.4.504 · Cited by 256
Li, P.-X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., & Klamut, H. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909580199 · Cited by 254
Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia
Vořechovský, I., Luo, L., Dyer, M. J. S., Catovsky, D., Amlot, P. L., Yaxley, J. C., Foroni, L., Hammarström, L., Webster, A. D. B., & Yuille, M. A. R. (1997) · Nature Genetics · doi:10.1038/ng0997-96 · Cited by 254
DNA Damage and Checkpoint Pathways
Weinert, T. (1998) · Cell · doi:10.1016/s0092-8674(00)81597-4 · Cited by 253
Misra, R. N., Xiao, H.-Y., Kim, K. S., Lu, S., Han, W.-C., Barbosa, S. A., Hunt, J. T., Rawlins, D. B., Shan, W., Ahmed, S. Z., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0305568 · Cited by 252
Heffernan, T. P., Simpson, D. A., Frank, A. R., Heinloth, A. N., Paules, R. S., Cordeiro-Stone, M., & Kaufmann, W. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8552-8561.2002 · Cited by 251
Mre11 Protein Complex Prevents Double-Strand Break Accumulation during Chromosomal DNA Replication
Costanzo, V., Robertson, K., Bibikova, M., Kim, E., Grieco, D., Gottesman, M., Carroll, D., & Gautier, J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00294-5 · Cited by 239
The role of BRCA1 in DNA damage response
Wu, J., Lu, L.-Y., & Yu, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0010-5 · Cited by 235
Chk2 Activation Dependence on Nbs1 after DNA Damage
Buscemi, G., Savio, C., Zannini, L., Miccichè, F., Masnada, D., Nakanishi, M., Tauchi, H., Komatsu, K., Mizutani, S., Khanna, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5214-5222.2001 · Cited by 201
Fan, F., Jin, S., Amundson, S. A., Tong, T., Fan, W., Zhao, H., Zhu, X., Mazzacurati, L., Li, X., Petrik, K. L., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205896 · Cited by 198
UBPY: a growth‐regulated human ubiquitin isopeptidase
Naviglio, S., Matteucci, C., Matoskova, B., Nagase, T., Nomura, N., Di Fiore, P. P., & Draetta, G. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3241 · Cited by 174
Anticancer and antiproliferative activity of natural brassinosteroids
Malíková, J., Swaczynová, J., Kolář, Z., & Strnad, M. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2007.07.028 · Cited by 170
Stewart, Z. A., Leach, S. D., & Pietenpol, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.205 · Cited by 168
Hypothesis: Ataxia‐telangiectasia: Is ATM a sensor of oxidative damage and stress?
Rotman, G., & Shiloh, Y. (1997) · BioEssays · doi:10.1002/bies.950191011 · Cited by 160
de la Torre‐Ruiz, M., Green, C. M., & Lowndes, N. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2687 · Cited by 147
Jones, D. L., & Münger, K. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2905-2912.1997 · Cited by 146
Recruitment of the Cell Cycle Checkpoint Kinase ATR to Chromatin during S-phase
Dart, D. A., Adams, K. E., Akerman, I., & Lakin, N. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314212200 · Cited by 124
Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells
Safwat, M. A., Soliman, G. M., Sayed, D., & Attia, M. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.09.076 · Cited by 109
Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation
ZHAN, Q., FAN, S., SMITH, M. L., BAE, I., YU, K., ALAMO, I., O'CONNOR, P. M., & FORNACE, A. J. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.805 · Cited by 97
Luke, J. J., D'Adamo, D. R., Dickson, M. A., Keohan, M. L., Carvajal, R. D., Maki, R. G., de Stanchina, E., Musi, E., Singer, S., & Schwartz, G. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3203 · Cited by 95
Neecke, H., Lucchini, G., & Pia Longhese, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4485 · Cited by 94
Bower, J. J., Vance, L. D., Psioda, M., Smith-Roe, S. L., Simpson, D. A., Ibrahim, J. G., Hoadley, K. A., Perou, C. M., & Kaufmann, W. K. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0009-7 · Cited by 76
Kanai, M., Shiozawa, T., Lü, X., Nikaido, T., & Fujii, S. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980501)82:9<1709::aid-cncr18>3.0.co;2-8 · Cited by 69
(2000) · PubMed · Cited by 67
Guan, X., Madabushi, A., Chang, D.-Y., Fitzgerald, M. E., Shi, G., Drohat, A. C., & Lu, A.-L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm678 · Cited by 65
Chaudhary, P., Sharma, R., Sahu, M., Vishwanatha, J. K., Awasthi, S., & Awasthi, Y. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467662 · Cited by 55
SHI, W., DENG, J., TONG, R., YANG, Y., HE, X., LV, J., WANG, H., DENG, S., QI, P., ZHANG, D., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4947 · Cited by 50
“Apoptotic cells have long been observed to display a series of morphological characteristics, including nuclear and cytoplasmic shrinkage, membrane blebbing, and shattering (13-15), thus suggesting the existence of common pathways involved in apoptotic cell death.”
RetractedRetinoblastoma tumor suppressor and genome stability
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)85002-3 · Cited by 48
Terry, N. H., & White, R. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.113 · Cited by 45
“Thus, these applications provide insight into cell-cycle regulatio”
Background(2010) · PubMed · Cited by 38
Saito, Y., Gopalan, B., Mhashilkar, A. M., Roth, J. A., Chada, S., Zumstein, L., & Ramesh, R. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700644 · Cited by 33
p53 is dispensable for UV-induced cell cycle arrest at late G1 in mammalian cells
Al-Mohanna, M. A., Al-Khodairy, F. M., Krezolek, Z., Bertilsson, P.-A., Al-Houssein, K. A., & Aboussekhra, A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.573 · Cited by 30
Maritz, G. S., & Rayise, S. S. (2011) · Experimental Lung Research · doi:10.3109/01902148.2010.515650 · Cited by 22
DNA binding by the Rad9A subunit of the Rad9-Rad1-Hus1 complex
Hwang, B.-J., Gonzales, R., Corzine, S., Stenson, E., Pidugu, L., & Lu, A.-L. (2022) · PLOS ONE · doi:10.1371/journal.pone.0272645 · Cited by 9
Metadata
- Authors
- Hartwell, L. H., & Kastan, M. B.
- Venue
- Science
- Published
- 1994-12-16
- Volume
- 266
- Issue
- 5192
- Pages
- 1821-1828
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2084147994
- Cited by
- 2,535
- References
- 156
- FWCI
- 58.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.